Table 2.
Studies that utilized cell-free repetitive DNA in clinical use of cancer patients.
| Clinical Use | Repeat Type | References |
|---|---|---|
| Evaluation of diagnostic potential of cedant | LINE1 | [41,42,43,44,46,47,48,49,51,52,54,55] |
| ALU | [44,49,61,62,63,64,65,66,67,68,69,70,71,72,74,75,76,77,79,98,99] | |
| Human satellite 2 | [80] | |
| Microsatellites | [81,82,85,86] | |
| Prognostic significance of cfDNA | LINE1 | [42,44,45,50,53,54,56,57,59] |
| ALU | [62,66,67,71,72,73] | |
| Microsatellites | [83] | |
| Predicting the response to neoadjuvant chemotherapy | ALU | [100,101,102] |
| Monitoring of cancer patients | LINE1 | [42,50,53,55,56,57] |
| ALU | [60,64,68,79] | |
| Microsatellites | [85,87] |